Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Seres Therapeutics Inc.

    Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent[...]

  • Portland Police Bureau

    PPB In Negotiations With Armed Suspect

  • New York City Council

    Speaker Adrienne E. Adams Outlines Vision Calling for Expanded Health[...]

More

Education

  • The University of Mississippi

    International Physics Conference Opens Monday at UM

  • CSU - California State University[...]

    Technical Details

  • Tarleton State University

    Tarleton drops slugfest to North Alabama in opening round of NISC[...]

More

ODP Corporation

11/17/2021 | Press release | Distributed by Public on 11/17/2021 05:03

The ODP Corporation Announces $150 Million Accelerated Share Repurchase and $150 Million Increase in its Existing Stock Repurchase Plan - Form 8-K

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | ODP Corporation | News | Education | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Buyback, Treasury Shares and Liquidity Agreements | Manufacturing | Lifestyle and Leisure | Leisure | Public Companies | Specialty Retailers | Börse Frankfurt | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | Proveedor Integral de Precios (PIP) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact